Rakovina Therapeutics Inc. (TSXV:RKV)
0.1650
+0.0100 (6.45%)
Nov 20, 2026, 1:12 PM EST
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 7.36 million as of November 20, 2026. It is the 44,487th most valuable company in the world and the 1,666th biggest in Canada. Its market cap has increased by 178.30% in one year.
Market Cap
7.36M
Enterprise Value
10.81M
Revenue
n/a
Global Rank
Country Rank
#1,666 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 7.36M, a decrease of -50.54%. That is a compound annual growth rate of -11.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 7.36M | 247.88% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PreveCeutical Medical | 12.76M |
| Rapid Dose Therapeutics | 12.40M |
| Britannia Life Sciences | 12.27M |
| Marvel Biosciences | 8.49M |
| COSCIENS Biopharma | 8.23M |
| Glow Lifetech | 6.74M |
| Hemostemix | 6.34M |
| Kane Biotech | 6.15M |